Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Дек. 9, 2024
Colorectal
cancer
(CRC)
is
a
leading
cause
of
cancer-related
deaths
globally.
The
heterogeneity
the
tumor
microenvironment
significantly
influences
patient
prognosis,
while
diversity
cells
shapes
its
unique
characteristics.
A
comprehensive
analysis
molecular
profile
crucial
for
identifying
novel
targets
drug
sensitivity
and
uncovering
pathophysiological
mechanisms
underlying
CRC.
Molecules,
Год журнала:
2023,
Номер
29(1), С. 35 - 35
Опубликована: Дек. 20, 2023
Spiders
(Araneae),
having
thrived
for
over
300
million
years,
exhibit
remarkable
diversity,
with
47,000
described
species
and
an
estimated
150,000
in
existence.
Evolving
intricate
venom,
spiders
are
nature’s
skilled
predators.
While
only
a
small
fraction
of
pose
threat
to
humans,
their
venoms
contain
complex
compounds,
holding
promise
as
drug
leads.
Spider
primarily
serve
immobilize
prey,
achieved
through
neurotoxins
targeting
ion
channels.
Peptides
constitute
major
part
these
venoms,
displaying
diverse
pharmacological
activities,
making
them
appealing
development.
Moreover,
spider-venom
peptides
have
emerged
valuable
tools
exploring
human
disease
mechanisms.
This
review
focuses
on
the
roles
spider
survival
strategies
dual
significance
pharmaceutical
research
tools.
By
integrating
recent
discoveries,
it
provides
comprehensive
overview
peptides,
targets,
bioactivities,
relevance
medical
research.
Pharmaceutics,
Год журнала:
2024,
Номер
16(1), С. 127 - 127
Опубликована: Янв. 19, 2024
Cucurbiturils
are
a
family
of
macrocyclic
oligomers
capable
forming
host–guest
complexes
with
various
molecules.
Due
to
noncovalent
binding
drug
molecules
and
low
toxicity,
cucurbiturils
has
been
extensively
investigated
as
potential
carriers
for
delivery.
However,
the
immune
system’s
interactions
different
carriers,
including
cucurbiturils,
still
under
investigation.
In
this
study,
we
focused
on
cucurbiturils’
immunosafety
immunomodulation
properties
in
vivo.
We
measured
blood
counts
lymphocyte
subpopulations
blood,
spleen,
bone
marrow,
assessed
vivo
toxicity
spleen
marrow
cells
after
intraperitoneal
administration
BALB/c
mice.
When
assessing
effect
cucurbit[6]uril
parameters
three
injections
within
week
laboratory
animals,
decrease
white
was
found
mice
cucurbit[6]util,
but
observed
number
normal
range.
At
same
time,
cucurbit[7]uril
cucurbit[8]uril
did
not
affect
leukocyte
injections.
Changes
platelets,
erythrocytes,
monocytes,
well
several
other
indicators,
such
hematocrit
or
erythrocyte
volumetric
dispersion,
were
detected.
show
that
do
have
immunotoxicity
vivo,
exception
cytotoxic
сucurbit[7]uril
at
high
dosage.
also
evaluated
cellular
humoral
responses.
founded
concentrations
system
action
differs
homologues,
which
is
apparently
associated
internal
environment
body.
International Journal of Cancer,
Год журнала:
2024,
Номер
155(1), С. 159 - 171
Опубликована: Фев. 22, 2024
Abstract
Colorectal
cancer
has
the
highest
mortality
rate
of
all
digestive
system
diseases.
Considering
debate
about
cytokines
and
biases
that
exist
in
traditional
observational
study
designs,
we
performed
a
two‐sample
Mendelian
randomization
(MR)
analysis
to
explore
association
circulating
with
CRC
risk.
In
this
study,
used
cytokine
genetic
variants
from
recently
published
genome‐wide
(GWAS)
including
14,824
European‐ancestry
participants.
Summary‐level
data
for
colorectal
were
obtained
analyses
FinnGen
consortium.
addition,
conducted
independent
supplementary
using
variation
large
public
GWAS
2021.
Among
91
factors,
only
found
IL‐12B
be
significantly
associated
risk
(odds
ratio
[OR]:
1.19;
95%
confidence
interval
[CI]:
1.00–1.42;
p
=
.046).
We
2021
higher
Interleukin‐12p70
levels
(IL‐12p70)
revealed
have
significant
positive
(OR:
1.27;
CI:
1.13–1.43;
<
1.22
×
10
−3
).
Moreover,
was
suggestively
correlated
an
elevated
level
vascular
endothelial
growth
factor
(VEGF)
1.17;
1.02–1.35;
.026),
macrophage
colony‐stimulating
(M‐CSF)
0.85;
0.76–0.96;
.005),
IL‐13
1.15;
1.02–1.30;
.028),
IL‐10
1.23;
1.01–1.49;
.037),
IL‐7
1.02–1.39;
.024).
Our
MR
studies
support
one
IL‐12
is
five
VEGF,
M‐CSF,
IL‐13,
IL‐10,
are
Extracellular
vesicles
(EVs)
are
lipid
bilayer-enclosed
released
by
cells.
EVs
encapsulate
proteins
and
nucleic
acids
of
their
parental
cell
efficiently
deliver
the
cargo
to
recipient
These
act
as
mediators
intercellular
communication
thus
play
a
crucial
role
in
various
physiological
pathological
processes.
Moreover,
hold
promise
for
clinical
use.
They
have
been
explored
drug
delivery
vehicles,
therapeutic
agents,
targets
disease
diagnosis.
In
landscape
cancer
research,
while
strides
made
EV-focused
physiopathology,
liquid
biopsy,
delivery,
exploration
immunotherapeutic
agents
may
not
seen
substantial
progress
date.
Despite
promising
findings
reported
animal
studies,
translation
EV-based
immunotherapeutics
encounters
challenges.
Here,
we
review
existing
strategies
used
immunotherapy,
aiming
propel
development
this
emerging
yet
field.
Abstract
Immunosuppression
is
a
major
hallmark
of
tumor
progression
in
non‐small
cell
lung
cancer
(NSCLC).
Cluster
differentiation
147
(CD147),
an
important
pro‐tumorigenic
factor,
closely
linked
to
NSCLC
immunosuppression.
However,
the
role
CD147
di‐methylation
immunosuppressive
microenvironment
(TME)
remains
unclear.
Here,
at
Lys148
(CD147‐K148me2)
identified
as
common
post‐translational
modification
(PTM)
that
significantly
associated
with
unsatisfying
survival
outcomes
among
sufferers,
especially
those
advanced
stages
disease.
The
methyltransferase
NSD2
catalyzes
generate
CD147‐K148me2.
Further
analysis
demonstrates
CD147‐K148me2
reestablishes
TME
and
promotes
progression.
Mechanistically,
this
interaction
between
cyclophilin
A
(CyPA)
CD147,
turn,
increases
CCL5
gene
transcription
by
activating
p38‐ZBTB32
signaling,
leading
increased
cell‐derived
secretion.
Subsequently,
CD147‐K148me2‐mediated
upregulation
facilitates
M2‐like
tumor‐associated
macrophage
(TAM)
infiltration
tissues
via
CCL5/CCR5
axis‐dependent
intercellular
crosstalk
cells
macrophages,
which
inhibited
blocking
targeted
antibody
12C8.
Overall,
study
reveals
CD147‐K148me2‐driven
development
immunosuppression,
provides
potential
interventional
strategy
for
PTM‐targeted
therapy.
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Май 23, 2024
Background
Kidney
cancer
is
a
prevalent
malignancy
with
an
increasing
incidence
worldwide.
Blood
cell
indices
and
inflammation-related
markers
have
shown
huge
potential
as
biomarkers
for
predicting
incidences,
but
that
not
clear
in
kidney
cancer.
Our
study
aims
to
investigate
the
correlations
of
blood
risk.
Methods
We
performed
population-based
cohort
prospective
analysis
using
data
from
UK
Biobank.
A
total
466,994
participants,
free
at
baseline,
were
included
analysis.
The
hazard
ratios
(HRs)
95%
confidence
intervals
(CIs)
risk
calculated
Cox
proportional
hazards
regression
models.
Restricted
cubic
spline
models
used
nonlinear
longitudinal
associations.
Stratified
analyses
identify
high-risk
populations.
results
validated
through
sensitivity
analyses.
Results
During
mean
follow-up
12.4
years,
1,710
participants
developed
showed
13
four
associated
incidence.
restricted
non-linear
relationships
Finally,
combined
stratified
analyses,
we
found
corpuscular
hemoglobin
concentration
(MCHC),
red
distribution
width
(RDW),
platelet
(PDW),
systemic
immune-inflammation
index
(SII),
product
count
neutrophil
(PPN)
related
enhanced
stable
results.
Conclusion
findings
identified
three
(MCHC,
RDW,
PDW)
two
(SII
PPN)
independent
factors
These
indexes
may
serve
predictors
aid
development
targeted
screening
strategies
at-risk
individuals.
Heliyon,
Год журнала:
2024,
Номер
10(7), С. e29216 - e29216
Опубликована: Апрель 1, 2024
Cancer-associated
fibroblasts
(CAFs)
provide
suitable
conditions
for
growth
of
tumor
cell
and
facilitate
progression.
Hence,
we
aimed
to
identify
a
CAFs-related
gene
signature
associated
with
the
prognosis
patients
breast
cancer
(BRCA).
We
downloaded
datasets
from
Gene
Expression
Omnibus
(GEO)
confirmed
correlation
between
CAFs
infiltration
scores
prognosis.
By
performing
weighted
co-expression
network
analysis
(WGCNA)
Lasso
Cox
regression
analysis,
constructed
four-gene
(COL5A3,
FN1,
POSTN,
RARRES2)
prognostic
model.
Based
on
median
risk
score
CAFs,
BRCA
were
divided
into
high-
low-risk
groups.
Compared
group,
in
high-risk
group
exhibited
poor
limited
response
immunotherapy.
Furthermore,
high
found
have
detrimental
due
induction
immunosuppressive
infiltration,
resulting
an
microenvironment.
Importantly,
that
overexpressing
FN1
POSTN
significantly
promoted
wound
healing
invasion
ability
cells
vitro
validation.
Taking
together,
identified
signature,
which
was
proven
be
reliable
indicator
therapeutic
efficacy
BRCA.
This
study
provided
evidence
novel
CAFs-based
stromal
therapy.